BIOLOGICALLY ACTIVE FORMULATION BASED ON CYCLODEXTRIN SUPRAMOLECULAR COMPLEXES
    3.
    发明授权
    BIOLOGICALLY ACTIVE FORMULATION BASED ON CYCLODEXTRIN SUPRAMOLECULAR COMPLEXES 有权
    生物活性FROMULIERUNG BASED环糊精超分子复合物

    公开(公告)号:EP1876890B1

    公开(公告)日:2012-08-08

    申请号:EP06754780.2

    申请日:2006-04-21

    申请人: ENDURA S.p.A.

    CPC分类号: A01N25/10

    摘要: The present invention provides a formulation characterized by the simultaneous presence in cyclodextrin based supramolecular complexes, of two components, one of which possesses insecticidal, acaricidal, fungicidal, snailcidal or vermicidal activity and the other possesses an activity synergistic with the first, enhancing its effectiveness. The biologically active substance is chosen from the following classes of chemical products: carbamates, organophosphates, thioureas, pentatomic or hexatomic heterocycles in which 1, 2 or 3 nitrogen atoms are present. The synergistic substance can be chosen from components containing at least one aromatic or non aromatic carbocyclic ring, such as piperonyl butoxide, sesamol, verbutin or MGK 264. For the same dose, the activity of the present formulations is greater than that of the mixture of the two active components alone or separately complexed with cyclodextrin. The process for preparing said formulation and its use for the activities herein indicated are further aspects of the present invention.

    PROCESS FOR OBTAINING ENANTIOMERS OF CHRYSANTHEMIC ACID
    6.
    发明授权
    PROCESS FOR OBTAINING ENANTIOMERS OF CHRYSANTHEMIC ACID 有权
    程序用于获得对映异构体的菊

    公开(公告)号:EP1853545B1

    公开(公告)日:2010-05-26

    申请号:EP06708307.1

    申请日:2006-02-16

    申请人: ENDURA S.p.A.

    摘要: A new process is described, easy to perform on industrial scale, with high yield, for obtaining enantiomers of chrysanthemic acid starting from mixtures containing them. The process involves reacting said mixtures with enantiomers of 2- dimethylamino-1-phenyl-1 ,3-propanediol (DMPP) and 2-dimethylamino-1-[4- (methylthio)phenyl]propane-1 ,3-diol (MTDP) as chiral selectors. The invention includes salts of chrysanthemic acid with the aforesaid chiral selectors as process intermediates. The process allows operation in a single solvent rather than in solvent mixtures difficult to recover and reuse, and the final crystallization product does not incorporate molecules of solvent. The bases used are then recovered and reused in subsequent separations.